Cambridge startup analyses ‘multi-omics’ data to discover new heart drugs
Cambridge-based CardiaTec has raised $6.5mn to accelerate drug discovery for cardiovascular diseases, such as heart attacks and strokes. Cardiovascular diseases are the leading cause of death globally...